195 related articles for article (PubMed ID: 32527027)
1. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of
Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL
Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027
[TBL] [Abstract][Full Text] [Related]
2. Glycated
Römhild K; Fischer CA; Mindt TL
ChemMedChem; 2017 Jan; 12(1):66-74. PubMed ID: 27902882
[TBL] [Abstract][Full Text] [Related]
3. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
4. Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide.
Kasten BB; Ma X; Liu H; Hayes TR; Barnes CL; Qi S; Cheng K; Bottorff SC; Slocumb WS; Wang J; Cheng Z; Benny PD
Bioconjug Chem; 2014 Mar; 25(3):579-92. PubMed ID: 24568284
[TBL] [Abstract][Full Text] [Related]
5. Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.
Bouziotis P; Gourni E; Patsis G; Psimadas D; Zikos C; Fani M; Xanthopoulos S; Loudos G; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Pirmettis I; Papadopoulos M
Bioorg Med Chem; 2013 Nov; 21(21):6699-707. PubMed ID: 24035515
[TBL] [Abstract][Full Text] [Related]
6. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
7. The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.
Prasanphanich AF; Lane SR; Figueroa SD; Ma L; Rold TL; Sieckman GL; Hoffman TJ; McCrate JM; Smith CJ
In Vivo; 2007; 21(1):1-16. PubMed ID: 17354608
[TBL] [Abstract][Full Text] [Related]
8. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
9. Development and Preclinical Evaluation of
Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a
Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
[TBL] [Abstract][Full Text] [Related]
12. Nuclear targeting with cell-specific multifunctional tricarbonyl M(I) (M is Re, (99m)Tc) complexes: synthesis, characterization, and cell studies.
Esteves T; Marques F; Paulo A; Rino J; Nanda P; Smith CJ; Santos I
J Biol Inorg Chem; 2011 Dec; 16(8):1141-53. PubMed ID: 21706254
[TBL] [Abstract][Full Text] [Related]
13. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E
Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304
[TBL] [Abstract][Full Text] [Related]
14. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
[TBL] [Abstract][Full Text] [Related]
15. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
16. Development of (99m)Tc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging.
Kimura H; Sampei S; Matsuoka D; Harada N; Watanabe H; Arimitsu K; Ono M; Saji H
Bioorg Med Chem; 2016 May; 24(10):2251-6. PubMed ID: 27073053
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
Koźmiński P; Gniazdowska E
Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
[TBL] [Abstract][Full Text] [Related]
19. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Brenneman K; Pili R; Pomper M; Carducci MA; Wagner HN
Bioconjug Chem; 2005; 16(1):43-50. PubMed ID: 15656574
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting with
Rezazadeh F; Sadeghzadeh N
Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
